Related Experiment Video
Updated: Mar 29, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Published on: December 10, 2016
Clinical Characteristics and Risk Factors of Clostridioides difficile Infection: A Case-Control Study in a
Duvan Arley Galindes-Casanova1,2, Edith Norela Benitez-Escobar1,2, Jorge Enrique Daza-Arana1
1Internal Medicine Specialization Program, Faculty of Health, Universidad Santiago de Cali, Cali 760035, Colombia.
None:
Objectives: This study aimed to describe the epidemiological and clinical characteristics and the potential risk factors associated with Clostridioides difficile infection (CDI) in a high-complexity healthcare center. Methods: This was a retrospective case-control study conducted from 2020 to 2022 with a cohort of participants aged ≥18 years with diarrhea (more than three liquid stools per day), which included a molecular testing request (the FilmArray Gastrointestinal [GI] PCR Panel) in a high-complexity clinic in Santiago de Cali, Colombia. Controls were randomly selected from the same institutional laboratory database at a 2:1 ratio, matched by age and sex, and required to test negative for C. difficile. Patients from other institutions were excluded to avoid exposure misclassification. Results: Our study included 147 participants (49 cases and 98 controls) and found a 22% infection prevalence among those who underwent molecular testing. When comparing CDI cases with controls, significant differences were observed in the univariate analysis: cases showed longer time to symptom resolution, longer post-diagnosis hospital stay, and greater exposure to in-hospital antibiotics for more than 7 days prior to symptom onset (p < 0.05). Among CDI cases, 55% were healthcare-associated and 18% were classified as severe, with an overall 30-day mortality of 15%. In the multivariate logistic regression model, three variables remained significantly associated with CDI: hospital stay longer than 10 days before symptom onset, antibiotic exposure in the previous 90 days, and in-hospital proton pump inhibitor use. Conclusions: CDI can present a wide range of clinical manifestations, so underdiagnosis should be avoided. Identifying risk factors, particularly in patients with hospital-acquired diarrhea, is crucial. Factors such as a hospital stay longer than 10 days before symptom onset and in-hospital exposure to PPIs or antibiotics in the last 90 days were significant in our study. Early recognition of these risk factors may reduce hospital stay, lower the risk of complications, and optimize healthcare resources.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Bacterial Gastroenteritis
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:

